Chad M Robins insider trades

Open-market stock purchases and sales by Chad M Robins, CEO and Chairman at Adaptive Biotechnologies Corp, from SEC Form 4 filings since Jul 1, 2019.

Recent trades

DateStockTradeValue
Aug 18, 2026ADPT Adaptive Biotechnologies CorpSold$6.8M
Aug 18, 2026ADPT Adaptive Biotechnologies CorpSold$5.1K
Aug 18, 2026ADPT Adaptive Biotechnologies CorpBought (not open market)—
Aug 17, 2026ADPT Adaptive Biotechnologies CorpSold$8M
Aug 17, 2026ADPT Adaptive Biotechnologies CorpBought (not open market)—
Aug 17, 2026ADPT Adaptive Biotechnologies CorpSold$64.6K
Apr 8, 2026ADPT Adaptive Biotechnologies CorpSold$566K
Apr 6, 2026ADPT Adaptive Biotechnologies CorpSold$1.2M
Mar 11, 2026ADPT Adaptive Biotechnologies CorpSold$4.3M
Mar 11, 2026ADPT Adaptive Biotechnologies CorpSold$1.9M
Mar 6, 2026ADPT Adaptive Biotechnologies CorpBought (not open market)—
Mar 4, 2026ADPT Adaptive Biotechnologies CorpBought (not open market)—
Mar 3, 2026ADPT Adaptive Biotechnologies CorpSold$785K
Mar 3, 2026ADPT Adaptive Biotechnologies CorpSold$38.4K
Mar 2, 2026ADPT Adaptive Biotechnologies CorpSold$4.6M
Feb 27, 2026ADPT Adaptive Biotechnologies CorpSold$2.9M
Feb 2, 2026ADPT Adaptive Biotechnologies CorpSold$2.3M
Jan 5, 2026ADPT Adaptive Biotechnologies CorpSold$1.9M
Dec 1, 2025ADPT Adaptive Biotechnologies CorpSold$2.4M
Nov 26, 2025ADPT Adaptive Biotechnologies CorpSold$703K
Nov 12, 2025ADPT Adaptive Biotechnologies CorpSold$28K
Nov 11, 2025ADPT Adaptive Biotechnologies CorpSold$18K
Nov 10, 2025ADPT Adaptive Biotechnologies CorpSold$1.3M

Companies traded

  • ADPT Adaptive Biotechnologies Corp: 160 sales, last Aug 18, 2026

Get free alerts when Chad M Robins files a new trade →